PIB India

GLP-1 Drugs Use, Risks, and Regulation

GLP-1 drugs, prescribed for type 2 diabetes and obesity, work by mimicking a natural hormone to regulate blood sugar and reduce appetite. While effective, they carry serious side effects and must be taken under specialist supervision. To curb misuse, India's Drug Controller General has intensified regulatory surveillance, inspecting businesses and warning of strict action against unauthorised sale and misleading promotion Read more: https://www.pib.gov.in/PressNoteDetails.aspx?NoteId=157978&ModuleId=3&reg=3&lang=1 -------------------------------------------------------------------- FOLLOW US ON: • TWITTER: @pib_india https://twitter.com/pib_india • FACEBOOK: @pibindia https://www.facebook.com/pibindia • INSTAGRAM: @pibindia https://www.instagram.com/pibindia • PUBLIC: @pibindia https://public.app/user/profile/9U6YF... • Visit Our Official Website: https://pib.gov.in/ • Read Our Blogs Here: https://pibindia.wordpress.com/ _____________ ABOUT US: Press Information Bureau (PIB) is the nodal agency of Government of India to disseminate information to print/electronic media on government policies, programmes, initiatives and achievements. PIB disseminates information through press releases, press notes, photographs, videos, infographics and also through social media platforms. It also organises Press Conferences, Press Briefings, Interviews of Ministers/Senior Officers for sensitising media persons on important policy initiatives of the Government.